Deerfield Management Company, L.P. (Series C) Neogenomics Inc Transaction History

Deerfield Management Company, L.P. (Series C)

$4.04 Billion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	SELL	$13.4 - $17.73 $337,465 - $446,512	-25,184 Reduced 72.64%	9,486 $139,000
Q2 2024 Aug 14, 2024	BUY	$13.01 - $15.77 $451,056 - $546,745	34,670 New	34,670 $480,000

Others Institutions Holding NEO

# of Institutions

281

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

Black Rock Inc. New York, NY

19.7M
Shares

$189 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$137 Million
0.0% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.53M
Shares

$62.8 Million
0.07% of portfolio
Janus Henderson Group PLC London, X0

6.17M
Shares

$59.3 Million
0.05% of portfolio
Brown Advisory Inc

6.16M
Shares

$59.2 Million
0.13% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.21B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account